Key facts
- This page summarizes Todd R. Patrick's Form 4 filing for Armata Pharmaceuticals, Inc. (ARMP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 Apr 2022, 15:55.
Todd R. Patrick - 13 Apr 2022 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)
- Reporting relationship
- Director
- Issuer ticker
- ARMP
- Reported as of
- 13 Apr 2022
- Net transaction value
- $0
- Reporting owner signature
- /s/ Todd R. Patrick
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Todd R. Patrick filed Form 4 for Armata Pharmaceuticals, Inc. (ARMP) on 15 Apr 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARMP
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +33,000
- Change %
- Price
- $0.000000
- Shares after
- 33,000
- Date
- 13 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 33,000
- Exercise price
- $5.11
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant.